Compare Rex Fang & Innovation Equity Premium Income ETF (FEPI) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rex Fang & Innovation Equity Premium Income ETF vs Eli Lilly And Co — how do they compare? Rex Fang & Innovation Equity Premium Income ETF trades at $41.87, while Eli Lilly And Co trades at $1,213.01 (market cap $1.08T). The key difference: Eli Lilly And Co pays a 0.57% dividend while Rex Fang & Innovation Equity Premium Income ETF pays none. Which is the better fit depends on your goals.
| FEPI | LLY | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $49.54 | $1.24K |
52-Week Low | $37.98 | $639.43 |
Market Cap | — | $1.08T |
Enterprise Value | — | $1.13T |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rex Fang & Innovation Equity Premium Income ETF
FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
